Cargando…
Bendectin and birth defects : the challenges of mass toxic substances litigation /
Benedictin was prescribed to more than thirty-five million American women from its introduction in 1956 until 1983, when it was withdrawn from the market. The drug's manufacturer, Merrill Dow Pharmaceuticals, a major U.S. pharmaceutical firm, joined a list of other companies whose product liabi...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Philadelphia :
University of Pennsylvania Press,
©1996.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000Ma 4500 | ||
|---|---|---|---|
| 001 | JSTOR_ocm45844376 | ||
| 003 | OCoLC | ||
| 005 | 20231005004200.0 | ||
| 006 | m o d | ||
| 007 | cr cn||||||||| | ||
| 008 | 010109s1996 pau ob 001 0 eng d | ||
| 040 | |a N$T |b eng |e pn |c N$T |d OCL |d OCLCQ |d YDXCP |d OCLCG |d OCLCQ |d TPH |d OCLCF |d OCLCQ |d OCLCO |d N$T |d JSTOR |d OCLCQ |d DEBBG |d P@U |d OCLCO |d OCLCA |d OCLCQ |d IOG |d OCLCO |d OCLCA |d TXC |d AU@ |d OCLCO |d LVT |d OCLCQ |d OCLCO |d OCLCQ |d OCLCA |d RDF |d OCLCO |d INARC |d OCLCO |d OCLCQ |d OCLCO | ||
| 019 | |a 966768657 | ||
| 020 | |a 0585330190 |q (electronic bk.) | ||
| 020 | |a 9780585330198 |q (electronic bk.) | ||
| 020 | |a 1512816418 |q (electronic bk.) | ||
| 020 | |a 9781512816419 |q (electronic bk.) | ||
| 020 | |z 0812232577 |q (alk. paper) | ||
| 020 | |z 9780812216455 | ||
| 029 | 1 | |a AU@ |b 000056711421 | |
| 029 | 1 | |a DEBBG |b BV043712591 | |
| 029 | 1 | |a GBVCP |b 1003560792 | |
| 035 | |a (OCoLC)45844376 |z (OCoLC)966768657 | ||
| 037 | |a 22573/ctt19dws2f |b JSTOR | ||
| 043 | |a n-us--- | ||
| 050 | 4 | |a KF1297.D7 |b G74 1996eb | |
| 072 | 7 | |a LAW |x 001000 |2 bisacsh | |
| 072 | 7 | |a LAW |x 012000 |2 bisacsh | |
| 072 | 7 | |a LAW |x 062000 |2 bisacsh | |
| 072 | 7 | |a POL |x 040030 |2 bisacsh | |
| 082 | 0 | 4 | |a 346.7303/8 |a 347.30638 |2 20 |
| 049 | |a UAMI | ||
| 100 | 1 | |a Green, Michael D., |d 1950- | |
| 245 | 1 | 0 | |a Bendectin and birth defects : |b the challenges of mass toxic substances litigation / |c Michael D. Green. |
| 260 | |a Philadelphia : |b University of Pennsylvania Press, |c ©1996. | ||
| 300 | |a 1 online resource (xiii, 368 pages) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a data file |2 rda | ||
| 504 | |a Includes bibliographical references (pages 353-359) and index. | ||
| 588 | 0 | |a Print version record. | |
| 505 | 0 | 0 | |t Frontmatter -- |t Contents -- |t Preface -- |t Acknowledgments -- |t Chapter 1. A Birth Defect Child Is Born -- |t Chapter 2. Locating Bendectin Within the Mass Toxic Landscape -- |t Chapter 3. The Science of Determining Toxic Causation -- |t Chapter 4. The Food and Drug Administration -- |t Chapter 5. The Wm. S. Merrell Company -- |t Chapter 6. A Mother's Quest -- |t Chapter 7. The Mekdeci Case -- |t Chapter 8. The Unraveling Of Mekdeci -- |t Chapter 9. The Proliferation of Bendectin Litigation -- |t Chapter 10. Litigating a Multidistrict Case -- |t Chapter 11. The Withdrawal of Bendectin -- |t Chapter 12. Forging a Mass Toxic Substances Trial -- |t Chapter 13. The Settlement and Unsettlement of MDL-486 -- |t Chapter 14. The MDL-486 Trial -- |t Chapter 15. Aggregative Procedure in Mass Toxic Substances Litigation -- |t Chapter 16. The Third Phase of Bendectin Litigation: Oxendine, Richardson, and the Individual Trials -- |t Chapter 17. The Legacy of Bendectin for Toxic Causation Law -- |t Chapter 18. The Lessons and Non-Lessons of Bendectin Litigation -- |t Selected Bibliography -- |t Index |
| 520 | |a Benedictin was prescribed to more than thirty-five million American women from its introduction in 1956 until 1983, when it was withdrawn from the market. The drug's manufacturer, Merrill Dow Pharmaceuticals, a major U.S. pharmaceutical firm, joined a list of other companies whose product liabilities would result in precedent-setting litigation. Before it was over, the Benedictin litigation would involve 2,000 claimants over a fifteen-year period. Michael D. Green offers a comprehensive overview of the Benedictin case and highlights many of the key issues in mass toxic substances litigation, comparing individual and collective forms of litigation, and illustrating the misunderstandings between scientists and lawyers about the role of science in providing evidence for the legal system. | ||
| 590 | |a JSTOR |b Books at JSTOR Evidence Based Acquisitions | ||
| 590 | |a JSTOR |b Books at JSTOR Demand Driven Acquisitions (DDA) | ||
| 590 | |a JSTOR |b Books at JSTOR All Purchased | ||
| 650 | 0 | |a Products liability |x Drugs |z United States. | |
| 650 | 0 | |a Toxic torts |z United States. | |
| 650 | 0 | |a Complex litigation |z United States. | |
| 650 | 0 | |a Bendectin (Trademark) |x Toxicology. | |
| 650 | 0 | |a Abnormalities, Human. | |
| 650 | 1 | 2 | |a Abnormalities, Drug-Induced |x legislation & jurisprudence |
| 650 | 1 | 2 | |a Consumer Product Safety |x legislation & jurisprudence |
| 650 | 2 | 2 | |a Doxylamine |x adverse effects |
| 650 | 2 | 2 | |a Doxylamine |x legislation & jurisprudence |
| 650 | 2 | 2 | |a Pyridoxine |x adverse effects |
| 650 | 2 | 2 | |a Pyridoxine |x legislation & jurisprudence |
| 651 | 2 | |a United States | |
| 650 | 6 | |a Responsabilité du fait des produits |x Médicaments |z États-Unis. | |
| 650 | 6 | |a Responsabilité pour dommages causés par les substances dangereuses |z États-Unis. | |
| 650 | 6 | |a Instances complexes |z États-Unis. | |
| 650 | 7 | |a LAW |x Administrative Law & Regulatory Practice. |2 bisacsh | |
| 650 | 7 | |a LAW |x Civil Procedure. |2 bisacsh | |
| 650 | 7 | |a LAW |x Legal Services. |2 bisacsh | |
| 650 | 7 | |a POLITICAL SCIENCE |x Government |x Judicial Branch. |2 bisacsh | |
| 650 | 7 | |a Abnormalities, Human |2 fast | |
| 650 | 7 | |a Bendectin (Trademark) |x Toxicology |2 fast | |
| 650 | 7 | |a Complex litigation |2 fast | |
| 650 | 7 | |a Products liability |x Drugs |2 fast | |
| 650 | 7 | |a Toxic torts |2 fast | |
| 651 | 7 | |a United States |2 fast | |
| 776 | 0 | 8 | |i Print version: |a Green, Michael D., 1950- |t Bendectin and birth defects. |d Philadelphia : University of Pennsylvania Press, ©1996 |z 0812216458 |w (DLC) 95042306 |w (OCoLC)33334546 |
| 856 | 4 | 0 | |u https://jstor.uam.elogim.com/stable/10.2307/j.ctt19dzcpv |z Texto completo |
| 938 | |a Internet Archive |b INAR |n bendectinbirthde0000gree | ||
| 938 | |a EBSCOhost |b EBSC |n 50353 | ||
| 938 | |a Project MUSE |b MUSE |n muse52189 | ||
| 938 | |a YBP Library Services |b YANK |n 12811210 | ||
| 938 | |a YBP Library Services |b YANK |n 2322435 | ||
| 994 | |a 92 |b IZTAP | ||